Annual Operating Profit
-$66.17 M
-$7.72 M-13.21%
30 June 2022
Summary:
Applied Genetic Technologies annual operaing income is currently -$66.17 million, with the most recent change of -$7.72 million (-13.21%) on 30 June 2022. During the last 3 years, it has fallen by -$7.72 million (-13.21%).AGTC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$17.34 M
+$380.00 K+2.14%
30 September 2022
Summary:
Applied Genetic Technologies quarterly operating income is currently -$17.34 million, with the most recent change of +$380.00 thousand (+2.14%) on 30 September 2022.AGTC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$67.09 M
-$919.00 K-1.39%
30 September 2022
Summary:
Applied Genetic Technologies TTM operating income is currently -$67.09 million, with the most recent change of -$919.00 thousand (-1.39%) on 30 September 2022.AGTC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -13.2% | -5.6% | -12.2% |
| 5 y5 years | -1421.3% | -44.6% | -292.4% |
AGTC Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -3579.2% | -257.6% | -738.2% |
Applied Genetic Technologies Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$17.34 M(-2.1%) | -$67.09 M(+1.4%) |
| June 2022 | -$66.17 M(+13.2%) | -$17.72 M(+30.5%) | -$66.17 M(+6.3%) |
| Mar 2022 | - | -$13.58 M(-26.4%) | -$62.24 M(-1.4%) |
| Dec 2021 | - | -$18.44 M(+12.3%) | -$63.14 M(+5.6%) |
| Sept 2021 | - | -$16.43 M(+19.1%) | -$59.81 M(+2.3%) |
| June 2021 | -$58.45 M(+24.5%) | -$13.79 M(-4.8%) | -$58.45 M(-1.3%) |
| Mar 2021 | - | -$14.49 M(-4.1%) | -$59.24 M(+5.4%) |
| Dec 2020 | - | -$15.12 M(+0.4%) | -$56.20 M(+12.4%) |
| Sept 2020 | - | -$15.06 M(+3.3%) | -$50.01 M(+6.5%) |
| June 2020 | -$46.94 M(+979.1%) | -$14.58 M(+27.4%) | -$46.94 M(+7.2%) |
| Mar 2020 | - | -$11.44 M(+28.1%) | -$43.80 M(+105.1%) |
| Dec 2019 | - | -$8.93 M(-25.5%) | -$21.36 M(+24.9%) |
| Sept 2019 | - | -$11.99 M(+4.8%) | -$17.10 M(+293.0%) |
| June 2019 | -$4.35 M(-80.6%) | -$11.44 M(-204.0%) | -$4.35 M(-1498.7%) |
| Mar 2019 | - | $11.01 M(-335.6%) | $311.00 K(-101.7%) |
| Dec 2018 | - | -$4.67 M(-717.9%) | -$18.39 M(-7.9%) |
| Sept 2018 | - | $756.00 K(-111.2%) | -$19.96 M(-10.8%) |
| June 2018 | -$22.38 M(-1276.9%) | -$6.78 M(-11.9%) | -$22.38 M(+21.6%) |
| Mar 2018 | - | -$7.70 M(+23.3%) | -$18.41 M(+59.4%) |
| Dec 2017 | - | -$6.24 M(+274.4%) | -$11.55 M(+266.1%) |
| Sept 2017 | - | -$1.67 M(-40.5%) | -$3.15 M(-265.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | $1.90 M(-191.0%) | -$2.80 M(+235.3%) | $1.90 M(-73.6%) |
| Mar 2017 | - | -$836.00 K(-138.8%) | $7.19 M(-26.6%) |
| Dec 2016 | - | $2.15 M(-36.5%) | $9.79 M(-6.8%) |
| Sept 2016 | - | $3.39 M(+36.3%) | $10.51 M(-603.3%) |
| June 2016 | -$2.09 M(-91.5%) | $2.49 M(+40.7%) | -$2.09 M(-83.4%) |
| Mar 2016 | - | $1.77 M(-38.4%) | -$12.61 M(-39.3%) |
| Dec 2015 | - | $2.87 M(-131.2%) | -$20.76 M(-26.7%) |
| Sept 2015 | - | -$9.21 M(+14.7%) | -$28.34 M(+15.5%) |
| June 2015 | -$24.53 M(+95.4%) | -$8.03 M(+25.6%) | -$24.53 M(+17.2%) |
| Mar 2015 | - | -$6.39 M(+35.9%) | -$20.93 M(+17.6%) |
| Dec 2014 | - | -$4.70 M(-13.1%) | -$17.80 M(+11.2%) |
| Sept 2014 | - | -$5.41 M(+22.2%) | -$16.00 M(+27.4%) |
| June 2014 | -$12.56 M(+249.4%) | -$4.42 M(+35.7%) | -$12.56 M(+33.3%) |
| Mar 2014 | - | -$3.26 M(+12.2%) | -$9.42 M(+32.5%) |
| Dec 2013 | - | -$2.90 M(+47.8%) | -$7.11 M(+42.2%) |
| Sept 2013 | - | -$1.97 M(+52.8%) | -$5.00 M(+39.1%) |
| June 2013 | -$3.59 M(+74.6%) | -$1.29 M(+35.3%) | -$3.59 M(+55.8%) |
| Mar 2013 | - | -$951.00 K(+19.5%) | -$2.31 M(+70.1%) |
| Dec 2012 | - | -$796.00 K(+42.1%) | -$1.36 M(+142.1%) |
| Sept 2012 | - | -$560.00 K | -$560.00 K |
| June 2012 | -$2.06 M | - | - |
FAQ
- What is Applied Genetic Technologies annual operaing income?
- What is the all time high annual operating profit for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly operating income?
- What is the all time high quarterly operating profit for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM operating income?
- What is the all time high TTM operating profit for Applied Genetic Technologies?
What is Applied Genetic Technologies annual operaing income?
The current annual operating profit of AGTC is -$66.17 M
What is the all time high annual operating profit for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual operaing income is $1.90 M
What is Applied Genetic Technologies quarterly operating income?
The current quarterly operating profit of AGTC is -$17.34 M
What is the all time high quarterly operating profit for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly operating income is $11.01 M
What is Applied Genetic Technologies TTM operating income?
The current TTM operating profit of AGTC is -$67.09 M
What is the all time high TTM operating profit for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM operating income is $10.51 M